The Regulatory and Quality Assurance team at Beacon Therapeutics is responsible for ensuring that all ophthalmic gene therapy products meet stringent regulatory standards and quality benchmarks. This team collaborates with cross-functional departments to navigate the regulatory landscape, manage submissions to health authorities, and implement robust quality systems that guarantee product safety and efficacy throughout the development lifecycle. Their efforts are crucial in facilitating smooth transitions from research to market, ultimately contributing to the restoration and improvement of vision in patients with retinal diseases.
View all